A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC)

Citation
J. Lokich et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 169-169
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
169 - 169
Database
ISI
SICI code
0923-7534(1998)9:<169:APOSTE>2.0.ZU;2-D